Top Employer-Paid Stories
Eli Lilly makes $3.8B psychedelics bet as federal support builds
By Kristen SmithbergThe AtaiBeckley acquisition follows new federal efforts to accelerate research, regulatory review and clinical preparations for psychedelic therapies.








